Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
March 22, 2018
HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2017 Results
TUCSON, Ariz., March 22, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, ...
March 22, 2018
La Jolla Pharmaceutical Company Announces Launch of GIAPREZA™ (angiotensin II) in the United States
SAN DIEGO, March 22, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (LJPC) today announced that GIAPREZA™ (angiotensin II), injection for intravenous infusion, is now commercially ...
March 22, 2018
Altimmune to Participate at the H.C. Wainwright Global Life Sciences Conference
GAITHERSBURG, Md., March 22, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, ...
March 22, 2018
Celyad Reports 2017 Financial and Operating Results and Expected Key Milestones for 2018
Celyad (Euronext Brussels:CYAD) (CYAD) (CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, today provides an update on its recent operations ...
March 22, 2018
Heron Therapeutics to Present at the 17th Annual Needham Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Heron Therapeutics, Inc. (HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of ...
March 22, 2018
TRACON Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference
SAN DIEGO, March 21, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
March 22, 2018
Neovasc Announces Year End 2017 Financial Results Conference Call and Webcast
VANCOUVER, March 21, 2018 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral ...
March 22, 2018
Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
SAN DIEGO, March 21, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced the pricing of an underwritten public offering of 8,500,000 shares of its common stock ...
March 22, 2018
VALNEVA Delivers Strong 2017 Financial Results and Advances Key R&D Programs
Lyon (France), March 22, 2018 - Valneva SE ("Valneva" or "the Company"), a fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines, ...
March 22, 2018
Zealand Pharma to present at the Needham Healthcare Conference, March 27, 2018 in New York
Copenhagen, March 22, 2018 - Britt Meelby Jensen, President and Chief Executive Officer (CEO) of Zealand Pharma, will present at the 17th Annual Needham Healthcare ...
March 22, 2018
Reata Announces Positive Top-Line Data for Treatment of PH-ILD With Bardoxolone Methyl From the Phase 2 Lariat Trial
IRVING, Texas, March 22, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA) (Reata or Company), a clinical-stage biopharmaceutical company, today announced positive top-line data from ...
March 22, 2018
Zealand Pharma convenes its Annual General Meeting 2018
Copenhagen, March 22, 2018 - Zealand Pharma A/S ("Zealand") convenes the Company`s ordinary Annual General Meeting to be held on Thursday April 19, 2018 at 3.00 ...
March 22, 2018
Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results
Zug, Switzerland, March 22, 2018 - Auris Medical Holding AG (EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in ...
March 21, 2018
EDAP TMS SA : EDAP Announces CIGNA as First Major U.S. Private Health Insurer to Cover HIFU for Prostate Procedure
Lyon, France, Austin, TX -- March 21, 2018 - EDAP TMS SA (EDAP) today announced that CIGNA became the first major U.S. private health insurance ...
March 21, 2018
Checkpoint Therapeutics Initiates Dose Expansion Portion of Phase 1 Trial of Anti-PD-L1 Antibody CK-301
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization ...
March 21, 2018
Eiger BioPharmaceuticals Announces Positive Guidance Following FDA Meeting on Hepatitis Delta Virus Registration Program
PALO ALTO, Calif., March 21, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today ...
March 21, 2018
Albireo to Present at 17th Annual Needham & Company Healthcare Conference
BOSTON, March 21, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
March 21, 2018
BrainStorm Appoints Two Leading Thought Leaders in the Fields of Neuroscience and Regenerative Medicine to its Scientific Advisory Board
HACKENSACK, N.J. and PETACH TIKVAH, Israel, March 21, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapies for neurodegenerative ...
March 21, 2018
Lipocine to Present at the 17th Annual Needham Healthcare Conference
SALT LAKE CITY, March 21, 2018 /PRNewswire/ -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, announced today that Dr. Mahesh Patel, Chairman, President and CEO, will ...
March 21, 2018
Achaogen Announces Date of FDA Advisory Committee Meeting for Plazomicin
SOUTH SAN FRANCISCO, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
Page 56 of 117